| Name | Title | Contact Details |
|---|
Furiex Pharmaceuticals, Inc., a drug development company, engages in the compound partnering business primarily in the United States. It collaborates with pharmaceutical and biotechnology companies to enhance the value of their drug candidates by applying its novel approach to drug development. The company’s products under development include Eluxadoline1, a mu opioid receptor agonist and delta opioid receptor antagonist, which is in Phase III clinical trials for the treatment of diarrhea-predominant irritable bowel syndrome; and Avarofloxacin1, a Phase III-ready fluoroquinolone antibiotic for the treatment of acute bacterial skin and skin structure infections. It is also developing SYR-472, which is in Phase III clinical trials for the treatment of Type-2 diabetes. In addition, the company has rights to compounds in various stages of development and commercialization, which includes Nesina, Liovel, Oseni, and Kazano for the treatment of Type-2 diabetes, as well as Priligy for the treatment of premature ejaculation. The company was founded in 1998 and is headquartered in Morrisville, North Carolina.
SH3 is a Overland Park, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Hialeah Hospital is a 378-bed acute care facility with an experienced medical staff of more than 900 employees. Since we first opened our doors in 1951, we have provided compassionate care to our neighbors and their friends and families. Because we know hospital trips are especially challenging for our elderly neighbors, we provide specially designed senior services including a Senior ER and an Acute Care for the Elderly (ACE) Unit.
Captain Lewis Residence is a Farmingdale, ME-based company in the Healthcare, Pharmaceuticals, and Biotech sector.